U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219030) titled 'A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants' on Oct. 17.
Brief Summary: This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerability.
Study Start Date: Oct. 08
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Emraclidine
Oral tablets
DRUG: Placebo
Oral tablets
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....